3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
14
Small Cell Lung Carcinoma
9
Carcinoma, Hepatocellular
9
Lung Neoplasms
8
Colorectal Neoplasms
7
Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Carcinoma, Renal Cell
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Neoplasm Metastasis
3
Melanoma
3
Breast Neoplasms
3
Small Cell Lung Cancer Extensive Stage
2
Sarcoma
2
Liver Neoplasms
2
Extensive Stage Lung Small Cell Carcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unresectable Hepatocellular Carcinoma
1
Stomach Neoplasms
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Interventions
Imatinib Mesylate
4
Sunitinib
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
ripretinib
1
pemigatinib
1
Surgical Instruments
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Ipilimumab
1
IDRX-42
1
CTLA-4 Antigen
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
atezolizumab
×
30 days
×
Clear all
No trials found.